Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

Abstract Background Long-acting injectable (LAI) antipsychotics, along with community treatment orders (CTOs), are used to improve treatment effectiveness through adherence among individuals with schizophrenia. Understanding real-world medication adherence, and healthcare resource utilization (HRU)...

Full description

Bibliographic Details
Main Authors: Kai On Wong, Scott W. Klarenbach, Karen J. B. Martins, Pierre Chue, Serdar M. Dursun, Mark Snaterse, Alexis Guigue, Helen So, Huong Luu, Khanh Vu, Lawrence Richer
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Psychiatry
Subjects:
Antipsychotics
Long-acting injection
Schizophrenia
Healthcare resource utilization
Healthcare cost
Community treatment order
Online Access:https://doi.org/10.1186/s12888-022-04075-y

Internet

https://doi.org/10.1186/s12888-022-04075-y

Similar Items